Patent Yard Sign in
Canadian application, no grantCanada

A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases

CA 2484654 A1 · Owner: Pharmacia Corporation · Inventors: Manning, Pamela T.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Therapeutic methods for the prevention and treatment of respiratory diseases or conditions are described, the methods including administering to a subject in need thereof a respiratory disease or condition effective amount of a selective inhibitor of inducible nitric oxide synthase.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed May 16, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 16, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMay 16, 2003
GrantedNo grant recorded
Term endedMay 16, 2023
Patent numberCA 2484654 A1
Classification (IPC)A61K31/44 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedMay 16, 2003Term endedMay 16, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.